Ethnic considerations in pharmacogenetic studies

被引：3
作者：
Branford, Ruth A. [1 ,2 ]
Pantelidis, Panagiotis [2 ]
Ross, Joy R. [1 ,2 ]
机构：
[1] St Josephs Hospice, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Interstitial Lung Dis Unit, Dept Populat Genet & Gene Therapy, Natl Heart & Lung Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 10期
关键词：
D O I：
10.1200/JCO.2007.15.5929
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1766 / 1767
页数：3
相关论文
共 3 条
  • [1] mdr-1 single nucleotide polymorphisms in ovarian cancer tissue:: G2677T/A correlates with response to paclitaxel chemotherapy
    Gréen, H
    Söderkvist, P
    Rosenberg, P
    Horvath, G
    Peterson, C
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (03) : 854 - 859
  • [2] Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: The Scottish randomised trial in ovarian cancer
    Marsh, Sharon
    Paul, Jim
    King, Cristi R.
    Gifford, Gillian
    McLeod, Howard L.
    Brown, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4528 - 4535
  • [3] Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
    Vasey, PA
    Jayson, GC
    Gordon, A
    Gabra, H
    Coleman, R
    Atkinson, R
    Parkin, D
    Paul, J
    Hay, A
    Kaye, SB
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (22): : 1682 - 1691
1